UCCS19158, Karen Mustian, YOCAS
Research Question:
not to be listed
Basic Study Information
Purpose:
This feasibility phase II randomized controlled trial examines the preliminary efficacy
of our standardized four-week YOCAS©® (Yoga for Cancer Survivors) intervention that
is delivered virtually on insomnia and sleep quality in cancer survivors.
Insomnia can be described as excessive daytime napping, difficulty falling asleep,
difficulty staying asleep, or waking up earlier than desired. The vast majority of
patients with cancer experience some form of sleep impairment post-treatment. Yoga
is safe, feasible, and effective for improving insomnia and sleep quality in cancer
survivors. However, most of the yoga intervention was delivered in person. With the
challenges and the social distancing regulation regarding the COVID-19 pandemic, adapting
to virtual behavioral intervention is critically important and needed. Whether the
yoga intervention delivered virtually to survivors provides a similar benefit of improving
insomnia and sleep quality is unknown.
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Karen Mustian
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search